REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

计划入组 201 人 · 首次发布于 2017 年 6 月 14 日

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

计划入组 132 人 · 首次发布于 2024 年 10 月 3 日

Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test

计划入组 1,649 人 · 首次发布于 2014 年 7 月 15 日

1-naphthaleneacetic acid

C₁₂H₁₀O₂

undisclosed therapeutics (REVEAL-Tx technology, gout)

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Early Stage Alzheimer's: New Guidelines Reveal 10-Year Window for Intervention Before Symptoms

Fractyl Health's Revita Procedure Shows Promise in Sustained Weight Loss Management

Fractyl Health's Revita Shows Promise in Maintaining Weight Loss After GLP-1 Discontinuation